CYTEA BIO is a pre-clinical stage biotech company developing therapeutic products by combining genetically unmodified effector cells and engineered targeting ligands. Its patented Pin™ Platform enables practically limitless combinations of effector mechanisms and targeting ligands for applications in oncology and immunology. CYTEA BIO is the first portfolio company of MedXCell, a European cell therapy venture builder with offices in Switzerland, France and the US. MedXCell focuses on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders, with the aim to turn promising academic ideas into commercially viable propositions.

Biotechnology

Health Care

Therapeutics

CYTEA BIO

CYTEA BIO's headquarters in Montpellier, France

Alan Cookson

Roger Stupp

Pierre Martineau

Pierre Magistretti

Nicolas De Tribolet

Javier Hernandez

Ariel Ruiz

Benedicte Fauvel

CYTEA BIO

Org chart

Teams

Offices

CYTEA BIO

Org chart

Teams

Offices

Related companies